2017 WFSBP指南:单相抑郁障碍的药物治疗

2017-04-03 世界生物精神病学会联合会 Int J Psychiatry Clin Pract. 2017 Apr 3:1-11.

抑郁症(MMD)是一种严重影响所有年龄段人群的情感障碍,其急性和维持治疗主要包括药物治疗以及心理治疗方法。“单相抑郁障碍生物疗法指南”概要包括急性,后续以及维持治疗,主要聚焦药物治疗方案。

中文标题:

2017 WFSBP指南:单相抑郁障碍的药物治疗

英文标题:

Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines.

发布日期:

2017-04-03

简要介绍:

抑郁症(MMD)是一种严重影响所有年龄段人群的情感障碍,其急性和维持治疗主要包括药物治疗以及心理治疗方法。“单相抑郁障碍生物疗法指南”概要包括急性,后续以及维持治疗,主要聚焦药物治疗方案。

 

拓展指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 WFSBP指南:单相抑郁障碍的药物治疗)] GetToolGuiderByIdResponse(projectId=1, id=214001c001a81ee7, title=2017 WFSBP指南:单相抑郁障碍的药物治疗, enTitle=Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines., guiderFrom=Int J Psychiatry Clin Pract. 2017 Apr 3:1-11., authorId=null, author=, summary=抑郁症(MMD)是一种严重影响所有年龄段人群的情感障碍,其急性和维持治疗主要包括药物治疗以及心理治疗方法。“单相抑郁障碍生物疗法指南”概要包括急性,后续以及维持治疗,主要聚焦药物治疗方案。 , cover=, journalId=null, articlesId=null, associationId=324, associationName=世界生物精神病学会联合会, associationIntro=Founded in 1974 in Buenos Aires, Argentina, the World Federation of Societies of Biological Psychiatry is a non-profit, international organization composed of over 60 national societies of biological psychiatry, representing over 4,500 professionals. As a world authority on biological psychiatry, WFSBP is also highly committed to pioneering and promoting the highest levels of education and dissemination within the field., copyright=0, guiderPublishedTime=Mon Apr 03 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>抑郁症(MMD)是一种严重影响所有年龄段人群的情感障碍,其急性和维持治疗主要包括药物治疗以及心理治疗方法。“单相抑郁障碍生物疗法指南”概要包括急性,后续以及维持治疗,主要聚焦药物治疗方案。 </P> <P> </P>拓展指南:, tagList=[TagDto(tagId=56401, tagName=单相抑郁障碍), TagDto(tagId=1113, tagName=药物治疗)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5860, appHits=144, showAppHits=0, pcHits=4400, showPcHits=2075, likes=172, shares=9, comments=1, approvalStatus=1, publishedTime=Thu Aug 10 22:08:15 CST 2017, publishedTimeString=2017-04-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Aug 10 22:08:15 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:28:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 WFSBP指南:单相抑郁障碍的药物治疗)])
2017 WFSBP指南:单相抑郁障碍的药物治疗
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099584, encodeId=4b512099584c8, content=还是不错的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:27:31 CST 2022, time=2022-11-10, status=1, ipAttribution=)]
    2022-11-10 ozzy

    还是不错的

    0